A novel Transformation Model© for personalized medicine laboratory systems-Reference-Cited by-同舟云学术

A novel Transformation Model© for personalized medicine laboratory systems

Published:2010-01 Issue:1 Volume:7 Page:87-94
ISSN:1741-0541
Container-title:Personalized Medicine
language:en
Short-container-title:Personalized Medicine

Author:

McKibben Linda J¹,Boone D Joe²,Marchibroda Janet³,Issa Amalia M⁴

Affiliation:

1. US FDA, MD, USA

2. Battelle Inc., Columbus, OH, USA

3. IBM Healthcare, Bethesda, MD, USA

4. Program in Personalized Medicine & Targeted Therapeutics; Department of Clinical Sciences and Administration, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 1441 Moursund St, Houston, TX 77030, USA.

Abstract

The role of health system laboratories is critical to the appropriate clinical integration of personalized medicine. We conducted semistructured interviews with experts and opinion leaders representing laboratory medicine, health policy and the diagnostics industry, to examine what is known about the real-world effectiveness of health laboratories as organizations. We describe and encourage the wider use of an evidence-based, novel Transformation Model© to prepare for the future and set goals for a better health system. A collaborative approach appropriately integrates the efficiency and high-quality expertise of the health laboratory system with the transformative vision of the personalized medicine community.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Molecular Medicine,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pme.09.66

Reference25 articles.

1. Assessing Patient Readiness for the Clinical Adoption of Personalized Medicine

2. Physician Survey of a Laboratory Medicine Interpretive Service and Evaluation of the Influence of Interpretations on Laboratory Test Ordering

3. Enhanced clinical consulting—moving toward the core competencies of laboratory professionals

4. SeguinR: Quebec doctors call for retesting.The Globe and Mail, 22 June (2009).

5. Canadian Broadcasting Corporation: Labs to re-examine samples from 2,100 Quebec breast cancer patients.CBC News, 9 July (2009).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating genomic tests from bench to bedside: a practical framework;BMC Medical Informatics and Decision Making;2012-10-19

2. Provision of personalized genomic diagnostic technologies for breast and colorectal cancer: an analysis of patient needs, expectations and priorities;Personalized Medicine;2011-07